[1]贾中芝,黄渊全,冯耀良,等.原发性肝癌经导管动脉化疗栓塞术治疗前后血清血管内皮生长因子与CT灌注成像的相关性研究[J].介入放射学杂志,2010,(01):23.
 JIA Zhongzhi,HUANG Yuanquan,FENG Yaoliang,et al.Correlation between serum VEGF level and CT perfusion imaging in patients with primary liver cancer pre-and post TACE[J].journal interventional radiology,2010,(01):23.
点击复制

原发性肝癌经导管动脉化疗栓塞术治疗前后血清血管内皮生长因子与CT灌注成像的相关性研究()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2010年01期
页码:
23
栏目:
肿瘤介入
出版日期:
2010-01-15

文章信息/Info

Title:
Correlation between serum VEGF level and CT perfusion imaging in patients with primary liver cancer pre-and post TACE
作者:
贾中芝黄渊全冯耀良施海彬
210029江苏南京医科大学第一附属医院介入放射科
Author(s):
JIA Zhong-zhi HUANG Yuan-quanFENG Yao-liangSHI Hai-bin
the First Hospital Affiliated to Nanjing Medical University,Nanjing210029,China
关键词:
原发性肝癌血管内皮生长因子CT灌注成像经导管动脉栓塞
分类号:
R735.7
文献标志码:
A
摘要:
目的探讨原发性肝癌(PLC)患者行经导管动脉栓塞(TACE)术前、术后血清血管内皮生长因子(VEGF)与肿瘤组织CT灌注参数的相关性。方法对18例PLC患者TACE术前1d,术后6~8d、32~40d行血清VEGF检测及CT灌注扫描成像(CTPI ),得到血清VEGF、肿瘤组织肝动脉灌注量(ALP)、门静脉灌注量(PVP)、肝动脉灌注指数(HPI )等参数值,并进行统计学分析。结果根据TACE治疗效果分为完全缓解(CR)组和部分缓解及无变化(PR+SD)组。术前两组血清VEGF及ALP、PVP、HPI 差异无统计学意义(P>0.05);术后6~8d两组血清VEGF及PVP较术前变化差异无统计学意义(P>0.05),而ALP、HPI 较术前明显降低(P<0.05)。术后32~40d,CR组血清VEGF较术前明显降低(P<0.05),PR+SD组则较术前增高,但差异无统计学意义(P=0.221)。血清VEGF与肿瘤组织ALP、HPI 呈正相关。结论血清VEGF能间接反映TACE术后肿瘤组织微血管及侧支循环生成情况;CTPI 能直观和定量反映肿瘤组织TACE术前后的血流动力学变化;血清VEGF与肿瘤组织ALP、HPI 呈正相关。故联合应用血清VEGF及CTPI 有助于TACE疗效的评价,对进一步治疗时间、方案的确定提供重要参考依据。

参考文献/References:

[1]Mathonnet M,Descottes B,Valleix D,et al.Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer,liver metastasis of colorectal cancer and hepatocellular carcinoma [J].World J Gastroenterol,2006,12:3782-3783.
[2]Zhao J,Hu J,Cai J,et al.Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma [J].China Med J,2003,116:772-776.
[3]李欣,冯敢生,郑传胜,等.肝动脉化疗栓塞对肿瘤血管生成影响的实验研究[J].中华放射学杂志,2002,36:689-693.
[4]Li ZW,Lu GE,Hu AG,et al.Relationship between VEGF expression,tumor angiogenesis and invasion,metastasis and prognosis of hepatocellular carcinoma [J].China J Mod Med,2003,13:15-20.
[5]Poon RT,Ng IO,Lau C,et al.Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma :A prospective study[J].Ann Surg,2001,233:227-235.
[6]Zhou J,Tang ZY,Fan J,et al.Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus[J].J Cancer Res Cli Oncol,2000,126:57-61.
[7]肖恩华,李锦清,黄洁夫.术前经动脉化疗栓塞对肝癌细胞增殖的影响[J].介入放射学杂志,2004,13:31-34.
[8]Li X,Feng GS,Zheng CS,et al.Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level[J].World J Gastroenterol,2004,10:2878-2882.
[9]Miles KA,Hayball MP ,Dixon AK.Functional images of hepatic perfusion obtained with dynamic CT[J].Radiology,1993,188:405-411.
[10]Leggett DA,Kelley BB,Bunce IH,et al.Colorectal cancer:diagnostic potential of CT measurements of hepatic perfusion and implication for contrast enhancement protocols[J].Radiology,1997,205:716-720.
[11]Van Beers BE,Leconte I,Materne R,et al.Hepatic perfusion parameters in chronic liver disease:dynamic CT measurements correlated with disease severity[J].AJR,2001,176:667-673.
[12]王爽,赵心明,林蒙,等.肝脏CT灌注成像在肝癌早期诊断中的价值[J].放射学实践,2008,23:280-284.
[13]陈昆涛,何健垣,郭瑞珍.肝癌化疗栓塞前后CT灌注特征与肿瘤血管生成相关性的实验研究[J].中国临床医学影像杂志,2007,18:591-593.
[14]Ma SH,Le HB,Jia BH,et al.Peripheral pulmonary nodules:Relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression[J].BMC Cancer,2008,8:186.
[15]Tsushima Y,Funabasama S,Aoki J,et al.Quantitative perfusion map of malignant liver tumors created from dynamic computed tomography data[J].Acad Radiol,2004,11:215-223.
[16]郑加贺,郭启勇,卢再鸣,等.CT灌注成像评价肝细胞癌TACE前后血供的初步经验[J].中国医学影像学杂志,2007,15:5-8.
[17]Jiang HJ ,Zhang ZR,Shen BZ,et al.Functional CT for assessment of early vascular physiology in liver tumors[J].Hepatobiliary Pancreat Dis Int ,2008,7:497-502.
[18]Chen G,Ma DQ,He W,et al.Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembo-lization for hepatocellular carcinoma [J].World J Gastroenterol,2008,14:5738-5743.[19]刘慧,曹觉,彭光春,等.肝细胞癌CT灌注参数与VEGF表达的相关性研究[J].中国医学影像学杂志,2005,13:244-247.[20]周作福,黄洪磊,徐彪,等.CT灌注扫描在肝肿瘤的临床应用[J].临床放射学杂志,2006,25:233-237.

相似文献/References:

[1]郭添胜,姜在波,黄明声,等.原发性肝癌合并糖尿病介入治疗的围手术期处理[J].介入放射学杂志,2000,(03):182.
[2]张根山,周胜利,张旭.原发性肝癌合并脾功能亢进的介入治疗[J].介入放射学杂志,2000,(03):183.
[3]钱晟,颜志平.门脉支架置放术治疗原发性肝癌伴门脉癌栓一例[J].介入放射学杂志,2000,(04):250.
[4]陈家焱,姬广翠,钱建华,等.原发性肝癌自发性破裂出血的介入治疗[J].介入放射学杂志,2008,(06):436.
 CHEN Jiayan,JI Guangcui,QIAN Jianhua,et al.Interventional treatment of primary liver cancer with spontaneous bleeding(3cases report)[J].journal interventional radiology,2008,(01):436.
[5]曹跃勇,朱军,徐晓茜,等.原发性肝癌动脉栓塞术后螺旋CT和彩色多普勒超声比较和评价[J].介入放射学杂志,2008,(10):709.
 CAO Yueyong,ZHU Jun,XU Xiaoxi,et al.Comparison and evaluation between helical computer tomography and color-Doppler ultrasonography in primary hepatocellular carcinoma after transcatheter arterial chemoembolization[J].journal interventional radiology,2008,(01):709.
[6]赵广生,徐克,梁松年,等.原发性肝癌TACE术后严重并发症原因及预防[J].介入放射学杂志,2008,(11):773.
 ZHAO Guangsheng,XU Ke,LIANG Songnian,et al.Causes and prevention of serious complication after transcatheter arterial chemoembolization for primary hepatic carcinoma[J].journal interventional radiology,2008,(01):773.
[7]王执民,吴智群.中晚期原发性肝癌DSA表现的分型及其临床意义[J].介入放射学杂志,1997,(03):133.
[8]王邦浩.影响肝癌介入治疗效果的因素及对策[J].介入放射学杂志,1998,(03):170.
[9]邢丽华.原发性肝癌的介入治疗次数及单纯栓塞的意义[J].介入放射学杂志,1998,(03):166.
[10]邓力,陈庆强,卢秋红.华蟾素配合介入治疗原发性肝癌临床观察[J].介入放射学杂志,1999,(01):43.

备注/Memo

备注/Memo:
收稿日期:2009-06-29
更新日期/Last Update: 2010-01-15